Brief: Processa Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Rule
Feb 6 (Reuters) - Processa Pharmaceuticals Inc PCSA.O :
* PROCESSA PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ
MINIMUM
BID PRICE RULE
Source text for Eikon: ID:nGNX24S9wN
Further company coverage: PCSA.O
((Reuters.Briefs@thomsonreuters.com;))